期刊文献+

不同方式注射骨髓间充质干细胞对溃疡性结肠炎大鼠模型的疗效 被引量:7

Comparison of therapeutic effects in different ways of bone marrow mesenchymal stromal cells injection in rats with ulcerative colitis
下载PDF
导出
摘要 目的对比心脏注射和鼠尾静脉注射骨髓间充质干细胞(bone marrow mesenchymal stromal cells,BMSCs)对溃疡性结肠炎(ulcerative colitis,UC)大鼠模型的疗效,并分析可能的治疗机制。方法体外扩增培养雄性SD大鼠的BMSCs,用5%三硝基苯磺酸(trinitrobenzenesulfonic acid,TNBS)/乙醇灌肠建立UC大鼠模型,并建立正常对照组D。造模后24 h,A组由心脏注射BMSCs悬液0.5 ml(含1×106个干细胞),B组由鼠尾静脉注射BMSCs悬液0.5 ml(含1×106个干细胞),C组由鼠尾静脉注射0.5 ml 0.9%氯化钠注射液,计算各组大鼠的疾病活动指数(disease activity index,DAI)。移植后7 d处死大鼠,光镜下观察结肠病理变化,及人性别确定区Y蛋白(human sex-determining region Y protein,SRY蛋白)、自杀相关因子(factor associated suicide,FAS)、G-蛋白偶联受体5(leucine-rich repeat containing g protein coupled receptor 5,Lgr5)的表达。结果 A组较B、C组DAI评分低(F=90.603,P<0.05),但A、B组间差异无统计学意义。干细胞移植组大鼠均检测到SRY蛋白,A组优于B组;C组Fas表达高于D组(t=9.494,P<0.05),A、B组Fas表达较C组下调,且A组低于B组,3组差异有统计学意义(F=38.6,P<0.05);A、B组LGR-5较C组表达明显增加,且A组较B组高,3组差异有统计学意义(F=24.7,P<0.05)。结论心脏注射BMSCs对UC的疗效优于鼠尾静脉注射;BMSCs可通过减轻肠道细胞凋亡、促进肠道干细胞再生起到对UC的治疗作用。 Objective To compare the efficacy of intracardiac injection and intravenous injection of bone marrow mesenchymal stromal cells (BMSCs) in rats with ulcerative colitis (UC) and analyze the therapeutic mechanism.Methods BMSCs from SD male rats were in vitro cultured.The rat model of UC was established by 5% trinitrobenzenesulfonic acid (TNBS)/ethanol enema.Group D was the control group.And 24 hours later,rats of group A were injected with 0.5 ml of BMSCs suspension via the heart (1 × 106).Rats of group B were injected with 0.5 ml of BMSCs suspension via tail vein (1 × 106).Rats of group C were injected with equal volume of normal saline via tail vein.Disease activity index (DA1) of rats in every group was observed and calculated.The rats were sacrificed at day 7 after injection.The pathological changes of the colon and the expression of human sex-determining region Y protein (SRY protein),factor associated suicide (FAS),leucine-rich repeat containing g protein coupled receptor 5 (Lgr5) were observed under microscope.Results DAI of group A was lower than that of group B and C (F=90.603,P < 0.05) but there were no differences between group A and B.The repairing of injured colon in group A was much better than in group B.The SRY protein could be detected in transplantation group.Compared with the control group,the expression of Fas in group C increased (t=-9.494,P < 0.05).Compared with group C,the expression of Fas in treatment group decreased.And the expression in group A was lower than in group B.There were significant difference among the three groups (F=38.6,P < 0.05).Compared with group C,the expression of LGR-5 in treatment group was significantly increased.And the expression in group A was higher than in group B.There were significant difference among the three groups (F=24.7,P < 0.05).Conclusion The efficacy of intracardiac injection of BMSCs is much better than the efficacy of intravenous injection in rats with UC.BMSCs plays a therapeutic role in rats with UC by reducing intestinal cells apoptosis and promoting intestinal stem cell regeneration.
出处 《解放军医学院学报》 CAS 2014年第11期1155-1159,共5页 Academic Journal of Chinese PLA Medical School
基金 首都医学发展科研基金项目(2009-3083)~~
关键词 骨髓间充质干细胞 移植 溃疡性结肠炎 大鼠 bone marrow mesenchymal stromal cells transplantation ulcerative colitis rats
  • 相关文献

参考文献20

  • 1Fan H,Shen L,Tang Q,et al.Effect of Wumeiwan on cytokines TNF-alpha,IL-6,IL-8,IL-10 and expression of NF-kappaBp65 in rats with ulcerative colitis[J].J Huazhong Univ Sci Technolog Med Sci,2009,29 (5):650-654.
  • 2Murano M,Maemura K,Hirata I,et al.Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate Sodium (DSS)-induced colitis[J].Clin Exp Immunol,2000,120 (1):51-58.
  • 3Khor B,Gardet A,Xavier RJ.Genetics and pathogenesis of inflammatory bowel disease[J].Nature,2011,474 (7351):307-317.
  • 4Cooney R,Baker J,Brain O,et al.NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation[J].Nat Med,2010,16 (1):90-97.
  • 5Hundorfean G,Neurath MF,Mudter J.Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease[J].Inflamm Bowel Dis,2012,18 (1):180-186.
  • 6Anderson CA,Boucher G,Lees CW,et al.Meta-analysis identifies 29 additional ulcerative colitis risk loci,increasing the number of confirmed associations to 47[J].Nat Genet,2011,43 (3):246-252.
  • 7Lochner M,Ohnmacht C,Presley L,et al.Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORgamma t and LTi cells[J].J Exp Med,2011,208(1):125-134.
  • 8Faghihi F,Baghaban Eslaminejad M.The effect of nano-scale topography on osteogenic differentiation of mesenchymal stem cells[J].Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2014,158 (1):5-16.
  • 9Ren G,Su J,Zhang L,et al.Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression[J].Stem Cells,2009,27 (8):1954-1962.
  • 10Stagg J,Galipeau J.Mechanisms of immune modulation by mesenchymal stromal cells and clinical translation[J].Curr Mol Med,2013,13 (5):856-867.

二级参考文献31

  • 1Szabo S, Deng X, Tolstanova G, Khomenko T, Pau-novic B, Chen L, Jadus M, Sandor Z. Angiogenicand anti-angiogenic therapy for gastrointestinalulcers: new challenges for rational therapeutic pre-dictions and drug design. Curr Phnrm Des 2011; 17:1633-1642 [PMID: 21548866 DOI: 10.2174/138161211796197034].
  • 2Tolstanova G, Khomenko T, Deng X, Szabo S, San-dor Z. New molecular mechanisms of the unexpect-edly complex role of VEGF in ulcerative colitis. Bio-chem Biophys Res Com mu n 2010; 399: 613-616 [PM1D:20682292 DOI: 10.1016/j.bbrc.2010.07.124].
  • 3Liu J, Liu C Sun B, Shi C, Qiao C, Ke X, Liu S, Liu KSun H. Differentiation of Rabbit Bone MesenchymalStem Cells into Endothelial Cells In Vitro and Pro-motion of Defective Bone Regeneration In Vivo. CellBiochem Biophys 2013 Aug 14. [Epub ahead of print][PMID: 23943083].
  • 4Maxson S, Lopez EA, Yoo D, Danilkovitch-Miagkova A, Leroux MA. Concise review: role ofmesenchymal stem cells in wound repair. Stem CellsTransl Med 2012; 1: 142-149 [PMID: 23197761 DOI:10.5966/sctm.2011-0018].
  • 5Pittenger MF, Mackay AM, Beck SC, Jaiswal RK,Douglas R, Mosca JD, Moorman MA, SimonettiDW, Craig S, Marshak DR. Multilineage potentialof adult human mesenchymal stem cells. Science1999; 284: 143-147 [PMID: 10102814 DOI: 10.1126/science.284.5411.143].
  • 6MacFarlane RJ, Graham SM, Davies PS, Korres N,Tsouchnica H, Heliotis M, Mantalaris A, Tsiridis E.Anti-inflammatory role and immunomodulation ofmesenchymal stem cells in systemic joint diseases:potential for treatment. Expert O卩in Ther Targets2013; 17: 243-254 [PMID: 23293906 DOI: 10.1517/14728222.2013.7469541.
  • 7Kuo YR, Chen CC, Goto S, Lin PY, Wei FC, ChenCL. Mesenchymal stem cells as immunomodula-tors in a vascularized composite allotransplanta-tion. Clin Dev Immunol 2012; 2012: 854846 [PMID:23227090 DOI: 10.1155/2012/854846].
  • 8Auletta JJ, Bartholomew AM, Maziarz KT, DeansRJ, Miller RH, Lazarus HM, Cohen JA. The poten-tial of mesenchymal stromal cells as a novel cellulartherapy for multiple sclerosis. Immunotherapy 2012;4: 529-547 [PMID: 22642335 DOI: 10.2217/imt.l2.41].
  • 9Fan H, Shen L, Tang Q, Xiong P, Shou Z, Liao Y,Liang L, Chen X. Effect of Wumeiwan on cytokinesTNF-alpha, IL-6, IL-8, IL-10 and expression of NF-kappaBp65 in rats with ulcerative colitis. J HuazhongUniv Sci Technolog Med Sci 2009; 29: 650-654 [PMID:19821103 DOI: 10.1007/sll596-009-0523-4].
  • 10Brenna 0, Furnes MW, Drozdov I, van BeelenGranlund A, Flatberg A, Sandvik AK, ZwiggelaarRT, Marvik R, Nordrum IS, Kidd M, Gustafsson BI.Relevance of TNBS-colitis in rats: a methodologicalstudy with endoscopic, histologic and Transcrip-tomic [corrected] characterization and correlationto IBD. PLoS One 2013; 8: e54543 [PMID: 23382912DOI: 10.1371 / journal.pone.0054543].

共引文献7

同被引文献95

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部